New drug offers hope for late-stage Hodgkin lymphoma patients

A recent trial has proved that brentuximab vedotin offers patients with advanced Hodgkin lymphoma a more effective option than chemotherapy.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news